Literature DB >> 10576037

Pharmacokinetics of tacrolimus: clinically relevant aspects.

N A Undre1, P Stevenson, A Schäfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10576037     DOI： 10.1016/s0041-1345(99)00788-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

Review 1.  Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.

Authors:  Alessio Provenzani; Andrew Santeusanio; Erin Mathis; Monica Notarbartolo; Manuela Labbozzetta; Paola Poma; Ambra Provenzani; Carlo Polidori; Giovanni Vizzini; Piera Polidori; Natale D'Alessandro
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.

Authors:  Wen-ying Shu; Jia-li Li; Xue-ding Wang; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2015-04-20       Impact factor: 6.150

3.  The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers.

Authors:  Michael A Tortorici; Virginia Parks; Kyle Matschke; Joan Korth-Bradley; Alain Patat
Journal:  Eur J Clin Pharmacol       Date:  2012-10-04       Impact factor: 2.953

4.  Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.

Authors:  Khaled Benkali; Lionel Rostaing; Aurélie Premaud; Jean-Baptiste Woillard; Franck Saint-Marcoux; Saik Urien; Nassim Kamar; Pierre Marquet; Annick Rousseau
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

5.  Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.

Authors:  W J Sam; M Aw; S H Quak; S M Lim; B G Charles; S Y Chan; P C Ho
Journal:  Br J Clin Pharmacol       Date:  2000-12       Impact factor: 4.335

Review 6.  Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.

Authors:  Guo-Xiang Hao; Lin-Lin Song; Dong-Feng Zhang; Le-Qun Su; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

7.  Pharmacokinetics of tacrolimus during pregnancy.

Authors:  Songmao Zheng; Thomas R Easterling; Jason G Umans; Menachem Miodovnik; Justina C Calamia; Kenneth E Thummel; Danny D Shen; Connie L Davis; Mary F Hebert
Journal:  Ther Drug Monit       Date:  2012-12       Impact factor: 3.681

8.  Storage and allogeneic transplantation of peripheral nerve using a green tea polyphenol solution in a canine model.

Authors:  Ken Nakayama; Ryosuke Kakinoki; Ryosuke Ikeguchi; Tomoyuki Yamakawa; Soichi Ohta; Satoshi Fujita; Takashi Noguchi; Scott Fm Duncan; Suong-Hyu Hyon; Takashi Nakamura
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-11-28

9.  Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients.

Authors:  P Dalal; G Shah; D Chhabra; Lorenzo Gallon
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-08-04

10.  Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.

Authors:  Hui Hong; Emmanuelle Coutanceau; Marion Leclerc; Laxmee Caleechurn; Peter F Leadlay; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.